Molecular imaging of prostate cancer

Prostate cancer is a common malignancy with various treatments from surveillance, surgery, radiation and chemotherapy. The institution of appropriate, effective treatment relies in part on accurate imaging. Molecular imaging techniques offer an opportunity for increased timely detection of prostate...

Full description

Saved in:
Bibliographic Details
Published in:British journal of radiology 2018-04, Vol.91 (1084), p.20170736-20170736
Main Authors: Boustani, Anne Marie, Pucar, Darko, Saperstein, Lawrence
Format: Article
Language:English
Subjects:
Biopsy
Diagnostic Radiology
Early Detection of Cancer
Humans
Male
Male genital system
Molecular Imaging - methods
Neoplasm Staging
Nuclear medicine
Oncology
PET
Prostatic Neoplasms - diagnostic imaging
Prostatic Neoplasms - pathology
Review
Risk Assessment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Prostate cancer is a common malignancy with various treatments from surveillance, surgery, radiation and chemotherapy. The institution of appropriate, effective treatment relies in part on accurate imaging. Molecular imaging techniques offer an opportunity for increased timely detection of prostate cancer, its recurrence, as well as metastatic disease. Advancements within the field of molecular imaging have been complex with some agents targeting receptors and others acting as metabolic intermediaries. In this article, we provide an overview of the most clinically relevant radiotracers to date based on a combination of the five states model and the National Comprehensive Cancer Network Guidelines.
ISSN:0007-1285
1748-880X
DOI:10.1259/bjr.20170736